Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Healthcare Sector Analysis

UpdatedApr 24, 2026
DataAggregated Company Financials
Companies14
  • 7D-4.7%
  • 3M-12.0%
  • 1Y-6.2%
  • YTD-11.4%

Over the last 7 days, the Healthcare industry has dropped 4.7%, driven by Fisher & Paykel Healthcare declining 5.4%. In contrast, Ryman Healthcare has gained 14%. The industry has fallen 6.2% in the last year. Earnings are forecast to grow by 21% annually.

Sector Valuation and Performance

Has the New Zealand Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 24 Apr 2026NZ$31.2bNZ$20.0bNZ$451.7m18.4x69.2x1.6x
Sun, 22 Mar 2026NZ$31.7bNZ$19.8bNZ$449.4m18.1x70.6x1.6x
Tue, 17 Feb 2026NZ$33.0bNZ$18.5bNZ$537.3m19.8x61.4x1.8x
Thu, 15 Jan 2026NZ$35.8bNZ$18.4bNZ$535.9m21.6x66.9x1.9x
Sat, 13 Dec 2025NZ$35.3bNZ$18.2bNZ$531.8m21.6x66.3x1.9x
Mon, 10 Nov 2025NZ$35.7bNZ$18.0bNZ$578.9m19.6x61.7x2x
Wed, 08 Oct 2025NZ$35.3bNZ$17.8bNZ$574.4m19.4x61.5x2x
Fri, 05 Sep 2025NZ$34.6bNZ$17.5bNZ$569.7m18.3x60.8x2x
Sun, 03 Aug 2025NZ$35.6bNZ$17.6bNZ$571.0m19.2x62.4x2x
Tue, 01 Jul 2025NZ$35.0bNZ$17.4bNZ$567.4m16x61.6x2x
Thu, 29 May 2025NZ$34.6bNZ$17.4bNZ$918.2m17.1x37.6x2x
Sat, 26 Apr 2025NZ$33.0bNZ$17.1bNZ$652.3m15.8x50.6x1.9x
Mon, 24 Mar 2025NZ$31.9bNZ$17.4bNZ$657.9m17.6x48.4x1.8x
Wed, 19 Feb 2025NZ$36.2bNZ$18.3bNZ$736.6m16.4x49.1x2x
Fri, 17 Jan 2025NZ$36.4bNZ$18.2bNZ$734.7m14.2x49.5x2x
Sun, 15 Dec 2024NZ$35.8bNZ$18.2bNZ$734.0m12.4x48.8x2x
Tue, 12 Nov 2024NZ$38.0bNZ$18.2bNZ$968.0m18x39.3x2.1x
Thu, 10 Oct 2024NZ$36.9bNZ$18.3bNZ$968.7m19.8x38.1x2x
Sat, 07 Sep 2024NZ$37.0bNZ$18.0bNZ$961.6m20.5x38.5x2.1x
Mon, 05 Aug 2024NZ$34.3bNZ$17.5bNZ$973.2m19.6x35.3x2x
Wed, 03 Jul 2024NZ$29.6bNZ$17.6bNZ$974.5m16.2x30.4x1.7x
Fri, 31 May 2024NZ$29.8bNZ$17.4bNZ$1.2b12.9x24.7x1.7x
Sun, 28 Apr 2024NZ$29.8bNZ$17.4bNZ$1.3b23.4x23.2x1.7x
Tue, 26 Mar 2024NZ$29.6bNZ$17.3bNZ$1.3b23.9x23x1.7x
Thu, 22 Feb 2024NZ$28.2bNZ$16.4bNZ$1.1b18x25x1.7x
Sat, 20 Jan 2024NZ$29.0bNZ$16.7bNZ$1.1b22.8x25.6x1.7x
Mon, 18 Dec 2023NZ$28.5bNZ$16.7bNZ$1.1b23.4x25.2x1.7x
Wed, 15 Nov 2023NZ$28.1bNZ$16.5bNZ$1.1b26.3x25.3x1.7x
Fri, 13 Oct 2023NZ$27.5bNZ$16.3bNZ$1.1b31x24.9x1.7x
Sun, 10 Sep 2023NZ$28.3bNZ$16.5bNZ$1.1b29.6x25.8x1.7x
Tue, 08 Aug 2023NZ$30.3bNZ$15.7bNZ$1.1b30x28.2x1.9x
Thu, 06 Jul 2023NZ$30.7bNZ$15.7bNZ$1.1b29.7x28.6x1.9x
Sat, 03 Jun 2023NZ$30.7bNZ$15.9bNZ$1.1b32.8x28.6x1.9x
Mon, 01 May 2023NZ$32.3bNZ$15.5bNZ$1.6b18.8x20.4x2.1x
Price to Earnings Ratio

20.4x


Total Market Cap: NZ$32.3bTotal Earnings: NZ$1.6bTotal Revenue: NZ$15.5bTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Healthcare Sector Price to Earnings3Y Average 42.9x202420252026
Current Industry PE
  • Investors are optimistic on the New Zealander Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 69.2x which is higher than its 3-year average PE of 42.9x.
  • The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 34% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare sector?

NZ Market-1.29%
Healthcare-4.72%
Healthcare Services-1.74%
Pharma-2.17%
Biotech-5.46%
Medical Equipment-6.01%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 45.3x.
    • Analysts are expecting annual earnings growth of 38.9%, which is higher than its past year's earnings decline of 14.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 45% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RYM Ryman HealthcareNZ$2.2814.0%
+NZ$284.1m		-1.7%PS2.9x
SUM Summerset Group HoldingsNZ$8.422.1%
+NZ$41.4m		-23.5%PE7.9x
OCA Oceania HealthcareNZ$0.731.4%
+NZ$7.2m		19.7%PE10.1x
TAH Third Age Health ServicesNZ$4.954.2%
+NZ$2.0m		66.1%PE18.1x
PHL Promisia HealthcareNZ$0.451.1%
+NZ$263.6k		16.9%PE20.2x

Latest News

FPH
NZ$35.98
Fisher & Paykel Healthcare
7D
-5.4%
1Y
7.2%

FPH: Upgraded Guidance And Sector Perform Rating Will Support Bullish Repricing

Analysts have trimmed their fair value estimate for Fisher & Paykel Healthcare by about NZ$0.10 to reflect slightly higher discount rate assumptions, while also acknowledging improved profit margin expectations and recent upgrades in Street price targets, including a move to NZ$36 at one major firm. Analyst Commentary Bullish Takeaways Bullish analysts point to the company’s updated guidance as a key reason for shifting to a more neutral stance, seeing this as support for the revised fair value and the NZ$36 price target.
RYM
NZ$2.28
Ryman Healthcare
7D
14.0%
1Y
-1.7%

RYM: Higher Discount Rate And Solid Margins Will Support Future Returns

Analysts have reduced their price target for Ryman Healthcare to NZ$3.16 from NZ$3.23. This change reflects updated assumptions for slightly higher discount rates, modestly different revenue growth expectations, and a small adjustment to projected profit margins and future P/E.
EBO
NZ$21.45
EBOS Group
7D
-3.2%
1Y
-41.2%

EBO: Index Removal And P/E Outlook Will Support Future Capital Efficiency Reassessment

Analysts have nudged their fair value estimate for EBOS Group to NZ$33.94 from NZ$33.59, reflecting slightly updated assumptions for long term profit margins and future P/E multiples, while keeping revenue growth and discount rate broadly unchanged. What's in the News EBOS Group Limited was removed from the S&P/ASX 200 Index, which can affect how some index funds and benchmark aware investors are exposed to the stock (Key Developments).
OCA
NZ$0.73
Oceania Healthcare
7D
1.4%
1Y
19.7%

OCA: Fair Value Will Depend On Firmer Margins And Revenue Outlook

Analysts have nudged their price target for Oceania Healthcare slightly lower to NZ$0.84, reflecting updated views on revenue growth assumptions, profit margins and the appropriate discount rate. Valuation Changes Fair Value: NZ$0.84 is unchanged, with the updated assumptions still pointing to the same indicative value.
AFT
NZ$3.55
AFT Pharmaceuticals
7D
-1.1%
1Y
34.0%
PEB
NZ$0.17
Pacific Edge
7D
-0.6%
1Y
53.5%
SUM
NZ$8.42
Summerset Group Holdings
7D
2.1%
1Y
-23.5%
RAD
NZ$0.40
Radius Residential Care
7D
-8.0%
1Y
42.9%
MEE
NZ$0.047
Me Today
7D
-6.0%
1Y
-16.1%
TAH
NZ$4.95
Third Age Health Services
7D
4.2%
1Y
66.1%
PHL
NZ$0.45
Promisia Healthcare
7D
1.1%
1Y
16.9%